InvestorsHub Logo
icon url

midastouch017

01/08/17 11:11 AM

#1594 RE: midastouch017 #1579

Clal Biotechnology is reporting a number of recent deals and developments by its portfolio companies, including the completion by Gamida Cell of procedures for another trial on patients with leukemia or lymphoma for the US Food and Drug Administration (FDA). Gamida Cell has also obtained FDA approval for a personalized vaccination against mutations created by the malignant tumor itself.

Published by Globes [online], Israel Business News - www.globes-online.com - on January 8, 2017

http://www.globes.co.il/en/article-neon-therapeutics-completes-70m-financing-round-1001170762